Optiver Holding’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$347K Buy
2,329
+388
+20% +$54.4K ﹤0.01% 797
2026
Q2
$245K Buy
+1,941
New +$256K ﹤0.01% 868
2024
Q4
– Sell
-7,168
Closed -$601K – 1102
2024
Q3
$601K Buy
+7,168
New +$547K ﹤0.01% 399
2024
Q1
– Sell
-25
Closed -$2.02K – 709
2023
Q4
$2.02K Buy
25
+20
+400% +$1.56K ﹤0.01% 477
2023
Q3
$375 Buy
+5
New +$385 ﹤0.01% 545
2022
Q2
– Sell
-68
Closed -$4K – 427
2022
Q1
$4K Sell
68
-134
-66% -$8.57K ﹤0.01% 482
2021
Q4
$14K Buy
202
+47
+30% +$3.24K ﹤0.01% 657
2021
Q3
$11K Sell
155
-187
-55% -$13.1K ﹤0.01% 566
2021
Q2
$24K Buy
+342
New +$22.8K ﹤0.01% 351

Other funds holding GILD

Optiver Holding's GILD Position: Q3 2026 in Review

Optiver Holding increased its Gilead Sciences (GILD) stake by 20% in Q3 2026, buying an estimated $54.4K and bringing the position to 2,329 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

Optiver Holding first reported a position in GILD in Q2 2021 and has held it in 9 quarters since. The position peaked at $601K in Q3 2024. 2,354 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Optiver Holding held 2,329 shares of Gilead Sciences worth $347K as of Q3 2026.
  • Optiver Holding bought 388 Gilead Sciences shares in Q3 2026, an estimated $54.4K.
  • Gilead Sciences made up ﹤0.01% of Optiver Holding's portfolio in Q3 2026, its #797 holding.
  • Optiver Holding first reported a position in Gilead Sciences in Q2 2021 and has held it in 9 quarters since.
  • Optiver Holding's Gilead Sciences position peaked at $601K in Q3 2024.
  • 2,354 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Optiver Holding's 13F filing for Q3 2026, filed 16 Nov 2026.